Skip to main content Skip to section navigation Skip to footer
CohBar, Inc.
  • Home
  • About
    • Overview
  • Programs & Pipelines
    • Overview
    • Our Approach
    • CB4211
    • CB5138 Analogs
    • Posters & White Papers
  • Patient Resources
    • Overview
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • SEC Filings
  • Partners
  • Careers
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Oct 13, 2016 9:00am EDT

CohBar, Inc. Announces Discovery of New Peptides in the Mitochondrial Genome

Sep 30, 2016 9:00am EDT

CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities

Aug 15, 2016 9:00am EDT

CohBar, Inc. Announces Second Quarter 2016 Financial Results

May 31, 2016 9:00am EDT

CohBar, Inc. to Hold 2016 Annual Shareholder Meeting and Investor Update June 14, 2016

May 13, 2016 9:05am EDT

CohBar, Inc. Announces First Quarter 2016 Financial Results

Apr 11, 2016 3:00pm EDT

CohBar, Inc. Announces Preclinical Proof-of-principle Publication for SHLP Mitochondrial-derived Peptides and their Role in Metabolic Regulation and Cell Viability

Mar 09, 2016 4:05pm EST

CohBar, Inc. Announces Fourth Quarter 2015 Financial Results

Mar 08, 2016 9:00am EST

CohBar, Inc. Appoints Simon Allen as Chief Executive Officer

Feb 24, 2016 11:37am EST

CohBar, Inc. to Announce 2015 Fourth Quarter Financial Results and Host Conference Call for Shareholders on March 9, 2016

Feb 03, 2016 4:15pm EST

CohBar, Inc. Engages Torrey Hills Capital

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Next Pagearrow_forward
©2023 CohBar, Inc. All Rights Reserved.
Privacy Policy Sitemap Terms of Use